Thank you for your participation! Click the link below to complete the evaluation for the program you attended:

• January 26, 2021 (Overland Park, KS and simulcast)
• February 17, 2021 (Las Vegas, NV)
• February 26, 2021 (Canton, OH)
• March 4, 2021 (Chevy Chase, MD)
• March 9, 2021 (Lincoln, NE)
• March 9, 2021 (Green Bay, WI)
• March 25, 2021 (Brooklyn, NY)
• May 18, 2021 (Denver, CO)

Clinical Resources from the National Comprehensive Cancer Network (NCCN)

• NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) for Kidney Cancer

• NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) for Management of Immunotherapy-Related Toxicities

• NCCN Guidelines for Patients^® Kidney Cancer

• NCCN Quick Guide™ Kidney Cancer

• NCCN Guidelines for Patients^® Immunotherapy Side Effects (Immune Checkpoint Inhibitors)

• NCCN Quick Guide™ Immunotherapy Side Effects (Immune Checkpoint Inhibitors)

Clinical Resources from Clinical Care Options (CCO) 
*The information below is available from CCO's website, which may have different terms of use and privacy policy.

• Downloadable slides from the live event

• On-demand webcast

• NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) for Managing Immune Checkpoint Inhibitor–Related Toxicities: An Interactive Decision Support Tool